01
Oral small molecule
Bezisterim
Investigational anti-inflammatory insulin sensitizer studied in Parkinson’s disease and Long COVID, with prior Alzheimer’s research.
Clinical-stage biotechnology
Follow the biology.
Advance the evidence.
BioVie is investigating new approaches to inflammation, insulin resistance and vascular physiology in neurological and advanced liver diseases.
01
Evidence before claimsEvery candidate is investigational. Study design, stage and limitations matter.
One connected research story
Complex diseases demand a wider lens.
BioVie’s programs examine how inflammation, metabolic signaling, cellular energy and vascular function may interact across diseases of aging and chronic illness.
Explore the scientific rationale
BioVie research platform
InflammationInsulin resistanceNeurodegenerationVascular physiologyView the science ↗Pipeline
Two candidates.
Focused questions.
Our programs are designed to test specific biological hypotheses in controlled clinical research.
02
Continuous infusion
BIV201
Investigational terlipressin formulation designed for portable-pump delivery in refractory ascites due to liver cirrhosis.
Investigational use only
Bezisterim and BIV201 are not approved for any indication. Safety and efficacy have not been established.
View full pipeline →Therapeutic areas
Research shaped by patient burden.
Plain-language context, the biological rationale and direct routes to source material.
01Parkinson’s disease
Testing a biology-led approach to movement symptoms in early disease.
Learn more ↗
02Long COVID
Studying brain fog and fatigue through inflammatory and metabolic pathways.
Learn more ↗
03Alzheimer’s disease
Learning from prior clinical research in cognition, biomarkers and epigenetics.
Learn more ↗
04Refractory ascites
Investigating continuous-infusion terlipressin for advanced liver disease.
Learn more ↗
Information for you
Start with what you need to know.
Different audiences ask different questions. Each path separates educational, medical and investor information.
Patients & caregiversUnderstand research and participation →Medical professionalsReview study and scientific resources →PartnersExplore collaboration opportunities →InvestorsAccess disclosures and filings →Evidence library
Read the source.
See the context.
Browse scientific presentations, publications and study resources. Emerging evidence should be weighed with study design, limitations and independent replication.
Open the evidence library →Investor decision center
Research the company.
Make your own decision.
Review BioVie’s official filings, current clinical milestones, stock symbols and material risks in one source-linked place. BioVie does not recommend buying or selling its securities.
Research BIVI and BIVIW →Quick answers
BioVie, in brief.
What is BioVie?+
A clinical-stage biotechnology company researching neurological, neurodegenerative and advanced liver diseases.
Are BioVie’s candidates approved?+
No. Bezisterim and BIV201 are investigational. Safety and efficacy have not been established.
Where can I find trial information?+
Visit the clinical trials page for SUNRISE-PD and ADDRESS-LC resources.